179 related articles for article (PubMed ID: 29869464)
41. Comparison of Abbott RealTime High-Risk HPV and Hybrid Capture 2 Assays for Detection of HPV Infection.
Ko K; Yu S; Lee EH; Park H; Woo HY; Kwon MJ
Ann Clin Lab Sci; 2016 Sep; 46(5):522-8. PubMed ID: 27650620
[TBL] [Abstract][Full Text] [Related]
42. Resolving repeatedly borderline results of Hybrid Capture 2 HPV DNA Test using polymerase chain reaction and genotyping.
Seme K; Fujs K; Kocjan BJ; Poljak M
J Virol Methods; 2006 Jun; 134(1-2):252-6. PubMed ID: 16417931
[TBL] [Abstract][Full Text] [Related]
43. The performance of Cobas HPV test for cervical cancer screening in Chinese female migrant workers.
He Y; Chen W; Guo Z; Yi D; Cai C; Shi Y; Long Y; Shi K
Epidemiol Infect; 2021 Aug; 149():e196. PubMed ID: 34369328
[TBL] [Abstract][Full Text] [Related]
44. Comparison of the SPF10-LiPA system to the Hybrid Capture 2 Assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa Rica.
Safaeian M; Herrero R; Hildesheim A; Quint W; Freer E; Van Doorn LJ; Porras C; Silva S; González P; Bratti MC; Rodriguez AC; Castle P;
J Clin Microbiol; 2007 May; 45(5):1447-54. PubMed ID: 17344361
[TBL] [Abstract][Full Text] [Related]
45. A Comparison of the Roche Cobas HPV Test With the Hybrid Capture 2 Test for the Detection of High-Risk Human Papillomavirus Genotypes.
Levi AW; Bernstein JI; Hui P; Duch K; Schofield K; Chhieng DC
Arch Pathol Lab Med; 2016 Feb; 140(2):153-7. PubMed ID: 26910220
[TBL] [Abstract][Full Text] [Related]
46. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
47. Aptima HPV Assay versus Hybrid Capture
Cook DA; Smith LW; Law J; Mei W; van Niekerk DJ; Ceballos K; Gondara L; Franco EL; Coldman AJ; Ogilvie GS; Jang D; Chernesky M; Krajden M
J Clin Virol; 2017 Feb; 87():23-29. PubMed ID: 27988420
[TBL] [Abstract][Full Text] [Related]
48. Optimal threshold for a positive hybrid capture 2 test for detection of human papillomavirus: data from the ARTISTIC trial.
Sargent A; Bailey A; Turner A; Almonte M; Gilham C; Baysson H; Peto J; Roberts C; Thomson C; Desai M; Mather J; Kitchener H
J Clin Microbiol; 2010 Feb; 48(2):554-8. PubMed ID: 20007387
[TBL] [Abstract][Full Text] [Related]
49. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.
Castle PE; Schiffman M; Burk RD; Wacholder S; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Lorincz A
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1394-9. PubMed ID: 12433717
[TBL] [Abstract][Full Text] [Related]
50. Comparison of the Abbott RealTime High Risk HPV test and the Roche cobas 4800 HPV test using urine samples.
Lim MC; Lee DH; Hwang SH; Hwang NR; Lee B; Shin HY; Jun JK; Yoo CW; Lee DO; Seo SS; Park SY; Joo J
J Virol Methods; 2017 May; 243():74-79. PubMed ID: 28161277
[TBL] [Abstract][Full Text] [Related]
51. Validation of ThermoFisher's Papspin for human papillomavirus detection in cervicovaginal specimens using PCR with GP5+/GP6+ primers and the Hybrid Capture II assay.
Weynand B; Delvenne P; Polet R; Guiot Y; Arafa M; Somja J; Galant C
Clin Microbiol Infect; 2010 Jun; 16(6):671-5. PubMed ID: 19689463
[TBL] [Abstract][Full Text] [Related]
52. Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities.
Cornall AM; Poljak M; Garland SM; Phillips S; Tan JH; Machalek DA; Quinn MA; Tabrizi SN
Eur J Clin Microbiol Infect Dis; 2017 Mar; 36(3):545-551. PubMed ID: 27822653
[TBL] [Abstract][Full Text] [Related]
53. Comparison of a Newly Developed HPV Genotyping Assay (Mojin HPV Kit) with Cobas 4800 HPV Test for Detection of High-Risk HPV in Specimens Collected in SurePath Solution.
Yang WW; Wang ZG; Chen GF; Shi JF; Chen J; Ma QH; Zhou J; Mao XD; Liu C; Yao XM
Clin Lab; 2018 Mar; 64(3):387-391. PubMed ID: 29739098
[TBL] [Abstract][Full Text] [Related]
54. Clinical validation of a type-specific real-time quantitative human papillomavirus PCR against the performance of hybrid capture 2 for the purpose of cervical cancer screening.
Depuydt CE; Benoy IH; Beert JF; Criel AM; Bogers JJ; Arbyn M
J Clin Microbiol; 2012 Dec; 50(12):4073-7. PubMed ID: 23052314
[TBL] [Abstract][Full Text] [Related]
55. Comparison of the cobas Human Papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests.
Gage JC; Sadorra M; Lamere BJ; Kail R; Aldrich C; Kinney W; Fetterman B; Lorey T; Schiffman M; Castle PE;
J Clin Microbiol; 2012 Jan; 50(1):61-5. PubMed ID: 22075592
[TBL] [Abstract][Full Text] [Related]
56. Comparison of CerviHPV and Hybrid Capture 2 HPV tests for detection of high-risk HPV infection in cervical swab specimens.
Zhao G; Tian Y; Du Y; Sun J; Wang Z; Ma Y; Zheng M
Diagn Cytopathol; 2019 May; 47(5):439-444. PubMed ID: 30569591
[TBL] [Abstract][Full Text] [Related]
57. HPV testing by cobas HPV test in a population from Catalonia.
Lloveras B; Gomez S; Alameda F; Bellosillo B; Mojal S; Muset M; Parra M; Palomares JC; Serrano S
PLoS One; 2013; 8(3):e58153. PubMed ID: 23483984
[TBL] [Abstract][Full Text] [Related]
58. Prevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assay.
Preisler S; Rebolj M; Untermann A; Ejegod DM; Lynge E; Rygaard C; Bonde J
PLoS One; 2013; 8(3):e59765. PubMed ID: 23533648
[TBL] [Abstract][Full Text] [Related]
59. Comparison of the hybrid capture 2 and cobas 4800 tests for detection of high-risk human papillomavirus in specimens collected in PreservCyt medium.
Wong AA; Fuller J; Pabbaraju K; Wong S; Zahariadis G
J Clin Microbiol; 2012 Jan; 50(1):25-9. PubMed ID: 22090403
[TBL] [Abstract][Full Text] [Related]
60. Comparison of the AdvanSure human papillomavirus screening real-time PCR, the Abbott RealTime High Risk human papillomavirus test, and the Hybrid Capture human papillomavirus DNA test for the detection of human papillomavirus.
Hwang Y; Lee M
Ann Lab Med; 2012 May; 32(3):201-5. PubMed ID: 22563555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
